Glims Tablet

About Glims 2 mg Tablet

Glims is a tablet containing glimepiride, a sulfonylurea medicine used to lower blood sugar in adults with type 2 diabetes when diet and exercise alone are not enough. It is available as a 2 mg tablet from Opsonin Pharma Limited.

There are 41 brands of Glimepiride listed in Bangladesh. 20 of them have a lower unit price than Glims. The lowest listed price is Mepid 1 mg Tablet at ৳ 2.51 per unit.

What is Glims 2 mg Tablet?

Glimepiride belongs to the sulfonylurea class of antidiabetic medicines. It works by stimulating the pancreas to release more insulin, which helps lower blood glucose levels. It is used as an adjunct to diet and exercise in adults with non-insulin-dependent (type 2) diabetes mellitus whose hyperglycaemia is not controlled by diet and exercise alone. It may also be used with metformin when diet, exercise, and either glimepiride or metformin alone do not provide adequate glycaemic control. Glims 2 mg tablets are manufactured by Opsonin Pharma Limited. The dose is determined by your doctor based on regular blood sugar monitoring.

Uses of Glims

Glims is indicated as an adjunct to diet and exercise to lower blood glucose in patients with non-insulin-dependent (type 2) diabetes mellitus whose hyperglycaemia cannot be controlled by diet and exercise alone. It may also be used together with metformin when diet, exercise, and glimepiride or metformin alone do not result in adequate glycaemic control. It is not for type 1 diabetes, diabetic ketoacidosis, or diabetic coma.

How to use Glims

Glims should be taken exactly as prescribed by your doctor. The dose is set based on regular checks of glucose in blood and urine, starting with a low dose and adjusting gradually if needed. The doctor decides the dose and course. Do not change the dose yourself. Take the tablet at the time your doctor advises, usually with or just before a meal, and follow your diet and exercise plan. If you miss a dose, ask your doctor or pharmacist what to do.

Side effects of Glims

Like all medicines, Glims can cause side effects. The most common is hypoglycaemia (low blood sugar), which may cause symptoms such as sweating, shakiness, or confusion. Other side effects include temporary visual impairment, nausea, vomiting, diarrhoea, abdominal pain, urticaria (hives), and a fall in blood pressure. If you experience any of these, contact your doctor. Severe hypoglycaemia can be serious and may require immediate medical attention.

Safety and precautions

Glims must not be used in pregnancy or while breastfeeding, as it may harm the baby; a changeover to insulin is necessary. Do not take it if you are allergic to glimepiride, other sulfonylureas, or sulfonamides, or if you have severe liver or kidney problems, or are on dialysis. It is not for type 1 diabetes, diabetic ketoacidosis, or diabetic coma. During the first weeks of treatment, the risk of low blood sugar may be higher, so careful monitoring is needed. Tell your doctor about all medicines you take, as many drugs can interact with glimepiride. Ask your doctor or pharmacist before starting or stopping any medicine.

Frequently asked questions

What is the price of Glims?

The listed price is ৳ 9.00. The site will show the current price. For the most up-to-date cost, check with your pharmacy or the site's price display.

What does the generic name glimepiride mean?

Glimepiride is the generic name of the active ingredient in Glims. It belongs to the sulfonylurea class of medicines, which are used to lower blood sugar in type 2 diabetes.

What is Glims used for and what kind of medicine is it?

Glims is a sulfonylurea antidiabetic medicine. It is used as an adjunct to diet and exercise to lower blood glucose in adults with type 2 diabetes whose hyperglycaemia is not controlled by diet and exercise alone. It may also be used with metformin.

How should Glims be taken?

Take Glims exactly as your doctor prescribes. The dose and course are decided by your doctor based on your blood sugar levels. Do not change the dose yourself. Follow your diet and exercise plan, and ask your doctor or pharmacist if you have any questions.

Indications

Glimepiride is indicated in following conditions-
  • Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone.
  • Glimepiride may be used concomitantly with metformin when diet, exercise, and Glimepiride or metformin alone does not result in adequate glycaemic control.
  • ... Read more
Glimepiride is indicated in following conditions-
  • Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone.
  • Glimepiride may be used concomitantly with metformin when diet, exercise, and Glimepiride or metformin alone does not result in adequate glycaemic control.
  • Glimepiride is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycaemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycaemic agent.
  • Combined use of Glimepiride and insulin may increase the potential for hypoglycaemia.

Pharmacology

Glimepiride is a sulfonylurea antidiabetic agent which decreases blood glucose concentration. The primary mechanism of action of Glimepiride appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells. Glimepiride acts in concert with glucose by improving the sensitivity of beta cells to physiological glucose stimulus, resulting in insulin secretion. In addition, extrapancreatic effects like reduction of basal hepatic glucose production, increased peripheral tissue sensitivity to insulin and glucose uptake may also play role in the activity of Glimepiride. In non-fasting diabetic patients, the hypoglycaemic action of a single dose of Glimepiride persists for 24 hours.

Dosage & Administration

In principle, the dosage of Glimepiride is governed by the desired blood sugar level. The dosage of Glimepiride must be the lowest which is sufficient to achieve the desired metabolic control. The initial and the maintenance doses are set based on the results of regular check of glucose in blood and urine. Monitoring of glucose levels in blood and urine also serves to detect either primary or secondary failure of therapy.

Initial dose and dose titration: the usual initial dose is 1 mg once daily, if necessary, the daily dose can be increased. Any increase can be based on regular blood sugar monitoring, and should be gradual, i.e., at intervals of 1 to 2 weeks, and carried out stepwise, as follows: 1 mg -> 2 mg -> 3 mg -> 4 mg -> 6 mg.

Dose in patients with well controlled diabetes: the usual dose range in patients with well controlled diabetes is 1 to 4 mg daily.

Distribution of doses: Timing and distribution of doses are decided by the physician, in consideration of the patient's current life-style. Normally, a single daily dose is sufficient. This should be taken immediately before a substantial breakfast or if none is taken immediately before the first main meal. It is very important not to skip meals after taking the drug.

Secondary dosage adjustment: As control of diabetes improves, sensitivity to insuiin increases; therefore, Glimepiride requirement may fall as treatment proceeds. To avoid hypoglycaemia, timely dose reduction or cessation of Glimepiride therapy must be considered. A dose adjustment must also be considered whenever the patient's weight or life-styie changes, or other factors arise which cause an increased susceptibility to hypo or hyperglycaemia.

Changeover from other oral antidiabetics to Glimepiride: There is no exact dosage relationship between Glimepiride and other oral blood sugar lowering agents. When substituting Glimepiride for other such agents, the initial daily dose is 1 mg; this applies even in changeover from maximum dose of other oral blood sugar lowering agents. Any dose increase should be in accordance with guideline given above in 'initial dose and dose titration'. Consideration must be given to the potency and duration of action of the previous blood sugar lowering agent. It may be necessary to interrupt treatment to avoid additive effects which would increase the risk of hypoglycaemia.

Interaction

Based on experience with Glimepiride and known interactions for other sulfonylureas, the following interactions must be considered.

In addition to insulin and other oral antidiabetic agents, drugs which may potentiate the hypoglycaemic action of Glimepiride include: ACE inhibitors, aminosalicylic acid, anabolic steroids and male sex hormones, azapropazone, chloramphenicol, ciofibrate, coumarin derivatives, cyclophosphamide, disopyramide, fenfluramine, fenyramidol, fibrates, fluconazole, fluoxetine, guanethidine, ifosfamide, MAO-inhibitors, miconazole, oxpentifylline (high dose parenteral), oxyphenbutazone, para-aminosalicylic acid, phenylbutazone, probenecid, quinolones, salicylates, sulphinpyrazone, sulfonamide antibiotics, tetracyclines, tritoqualine, trofosfamide.

Drugs which may attenuate the hypoglycaemic action of Glimepiride include:
  • Acetazoiamide, barbiturates, calcium channel blockers, corticosteroids, diazoxide, diuretics, glucagon, isoniazid, laxatives, nicotinic acid (high doses), oestrogens, phenothiazines, phenytoin, progestagens, rifampicin, sympathomimetic agents, thyroid hormones.
  • H2 receptor antagonists, beta-blockers, clonidine and reserpine may lead to either potentiation or weakening of the blood-glucose-lowering effect.
  • Concomitant treatment with a beta-receptor blocker, clonidine, guanethidine or reserpine may mask the warning symptoms of a hypoglycaemic attack.
  • Acute and chronic aicohol intake may either potentiate or attenuate the activity of Glimepiride in an unpredictable fashion.

Contraindications

Glimepiride is not suitable for the treatment of insulin dependent (type I) diabetes mellitus, or for the treatment of diabetic ketoacidosis, nor for the treatment of diabetic coma. Glimepiride must not be used in patients hypersensitive to Glimepiride, other sulfonylureas, other sulfonamides, severe hepatic dysfunction, severe impairment of renal function and dialysis patients.

Side Effects

Hypoglycaemia, temporary visual impairment, nausea, vomiting, diarrhoea, abdominal pain, urticaria, fall in blood pressure.

Pregnancy & Lactation

Glimepiride must not be taken during pregnancy; a changeover to insulin is necessary. Patients planning a pregnancy must inform their physician, and should change over to insulin. Ingestion of Glimepiride with breast milk feeding may harm the child. Therefore, Glimepiride must not be taken by breastfeeding women. Either a changeover or complete discontinuation of breastfeeding is necessary.

Precautions & Warnings

in the initial weeks of treatment, the risk of hypoglycaemia may be increased and necessitates careful monitoring. If such risk present it may be necessary to adjust the dosage of Glimepiride, Hypoglycaemia can almost be promptly controlled by immediate intake of carbohydrates (glucose or sugar).

Overdose Effects

Overdosage of sulfonylureas, including Glimepiride, can produce hypoglycaemia. Mild hypoglycaemic symptoms without loss of consciousness or neurologic findings should be treated aggressively with oral glucose and adjustments in drug dosage or meal patterns. Close monitoring should continue until the physician is assured that the patient is out of danger. Severe hypoglycaemic reactions with coma, seizure, or other neurological impairment occur infrequently, but constitute medicai emergencies requiring immediate hospitalization. If hypoglycaemic coma is diagnosed or suspected, the patient should be given a rapid intravenous injection of  concentrated (50%) glucose solution. This should be followed by a continuous infusion of a more dilute (10%) glucose solution at a rate that will maintain the blood glucose at a level above 100 mg/dl. Patients should be closely monitored for a minimum of 24 to 48 hours, because hypoglycaemia may recur after apparent clinical recovery.

Storage Conditions

Do not store above 30°C. Keep away from light and out of the reach of children.

Alternative brands of Glimepiride

Other brands with the same generic name, cheapest first.

See all 41 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.